中文 | English
Return
Total: 157 , 1/16
Show Home Prev Next End page: GO
MeSH:(Paclitaxel/therapeutic use)

2.Median effective effect-site concentration of intravenous anesthetics for loss of consciousness in neoadjuvant chemotherapy patients.

Zi-jing HE ; Yong-hua HU ; Zhi-yi FAN

Chinese Medical Journal 2011;124(4):504-508

3.Synergistic effect of Hsp90 inhibitor ginkgolic acids C15 ꞉1 combined with paclitaxel on nasopharyngeal carcinoma.

Hui MA ; Di HUANG ; Bohan LI ; Feng DING ; Hongmei LI ; Chengzhu WU

Journal of Central South University(Medical Sciences) 2023;48(8):1128-1135

7.Efficacy and survival outcomes of dose-dense carboplatin plus paclitaxel as neoadjuvant chemotherapy for triple-negative breast cancer.

Yang LIU ; Meng XIU ; Xiang WANG ; Qing LI ; Jia Yu WANG ; Ying FAN ; Qiao LI ; Shan Shan CHEN ; Rui Gang CAI ; Hong Nan MO ; Fei MA ; Yang LUO ; Bing He XU ; Pin ZHANG

Chinese Journal of Oncology 2022;44(2):178-184

8.A real-world study on the efficacy and safety analysis of paclitaxel liposome in advanced breast cancer.

Chun Xiao SUN ; Shu Sen WANG ; Jian Bin LI ; Yong Sheng WANG ; Qu Chang OUYANG ; Jin YANG ; Hai Bo WANG ; Xiao Jia WANG ; Wen Yan CHEN ; Peng YUAN ; Min YAN ; Ze Fei JIANG ; Yong Mei YIN

Chinese Journal of Oncology 2023;45(1):88-94

9.Efficacy and safety analysis of paclitaxel liposome and docetaxel for the neoadjuvant chemotherapy of breast cancer.

Wei SU ; Sheng ZHANG ; Chunyan LI ; Xiaomeng HAO ; Jin ZHANG ; Email: ZHANGJIN@TJMUCH.COM.

Chinese Journal of Oncology 2015;37(5):379-382

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 157 , 1/16 Show Home Prev Next End page: GO